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The Will-o’-the-Wisp of Genetics — Hunting  
for the Azoospermia Factor Gene
Chris Tyler-Smith, Ph.D., and Csilla Krausz, M.D., Ph.D.
It has been known for decades that the Y chro-
mosome carries genes required for spermatogen-
esis and male fertility. But it has been frustrat-
ingly difficult to pin down the relevant genes, to 
such an extent that a finding reported by Luddi 
et al.1 in this issue of the Journal — that the ubiq-
uitin-specific peptidase 9, Y-linked gene (USP9Y) 
is not essential for normal spermatogenesis — 
represents a noteworthy advance in the field.
Approximately 15% of couples have difficulty 
conceiving; the causes are many and include ge-
netic factors. The most common known genetic 
causes of spermatogenic failure are karyotype 
anomalies and Y-chromosome microdeletions. 
Karyotype analysis and screening for Yq deletions 
are now routine diagnostic tests that are able to 
help elucidate both the cause of spermatogenic 
perturbations and their clinical consequences. It 
is therefore of some interest to know which genes 
are essential to spermatogenesis; with this infor-
mation, a more specific diagnosis might be pos-
sible, and the clinical management — including 
genetic counseling — of infertile couples would 
be greatly improved.
The search for these genes began in 1976, when 
Tiepolo and Zuffardi2 reported cytogenetically vis-
ible microdeletions in Yq in six azoospermic men. 
Such deletions must be very large to be visible and 
are therefore likely to involve the absence of many 
genes (and unlikely to reveal the causal gene), but 
this observation provided a starting point for a 
classic approach to identifying the gene or genes 
responsible for this phenotype. Smaller deletions 
within the Yq interval would be sought using mo-
lecular methods, leading to the identification of 
one or a few candidate genes, and inactivating 
mutations would then be used to confirm which 
of the candidates was responsible. This strategy 
has proved successful in the identification of the 
causal genes underlying countless single-gene dis-
orders since its initial application to chronic gran-
ulomatous disease in 1986.3
At first, the application of this approach for 
Y-chromosomal spermatogenic abnormalities 
seemed promising. Molecular analysis did indeed 
identify smaller deletions within Yq that were spe-
cific to men with spermatogenic failure. These 
were classified, on the basis of chromosomal lo-
cation, as three azoospermia factor (AZF) regions: 
AZFa, AZFb, and AZFc.4 AZFb and AZFc were later 
shown to contain large segments of duplicated 
sequence and, in fact, to overlap each other. Given 
the challenge of tracking down specific loci in 
chromosomal regions enriched in sequence dupli-
cations, it is perhaps understandable that the gene 
or genes responsible for the AZFb–AZFc spermato-
genesis phenotype have still not been identified.
In contrast, the AZFa interval consists of reg-
ular single-copy DNA (i.e., DNA that does not 
contain a supranormal level of repeated sequence) 
that should not present unusual complications for 
homing in on the key gene. And in 1999, Sun et 
al.5 described what seemed to be a definitive re-
sult. They sequenced the two genes in the AZFa 
region (USP9Y and the DEAD [Asp–Glu–Ala–Asp] 
box polypeptide 3, Y-linked gene, DDX3Y) in 576 
infertile men and discovered exactly the kind of 
mutation they were looking for, in a man with 
spermatogenic failure: a de novo deletion of 4 bp 
within the USP9Y gene that destroyed a splice-
donor site, resulting in the skipping of the next 
exon and truncation of approximately 90% of the 
peptide sequence (Fig. 1). Thus, it appeared that 
the loss of USP9Y was responsible for the observed 
azoospermia and that one gene underlying sper-
matogenic failure had been successfully found.
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But subsequent findings complicated this sim-
ple conclusion. The phenotype associated with the 
loss of USP9Y turned out to be variable, ranging 
from normospermia in chimpanzees and bono-
bos, in which the gene became inactivated mil-
lions of years ago,8 to moderate oligoasthenotera-
tozoospermia in humans,7 to azoospermia.5 The 
report by Luddi et al. now adds normospermia in 
humans to this list of phenotypes. These obser-
vations have bearing on two related questions: Is 
the inactivation of USP9Y or DDX3Y responsible for 
the AZFa azoospermic phenotype? and What con-
clusions should we draw from the variation in 
the USP9Y-associated phenotype?
There are a number of reasons why the first, 
apparently simple, question has been so difficult 
to resolve. First, AZFa deletions are themselves 
rare. In literature reports, they represent less than 
5% of all AZF deletions.9 Second, AZFa deletions 
leading to azoospermia obviously cannot be in-
herited, and so all are de novo mutations. They 
usually arise by the same mechanism: homologous 
recombination between two misaligned human 
endogenous retrovirus sequences (HERVs, ele-
ments of viral origin inserted into the genome 
and inherited as part of the chromosome) spaced 
about 790 kb apart (Fig. 1), encompassing both 
genes.10 Mutations due to HERV misalignment 
are therefore not informative for distinguishing 
between the contributions of the two genes. Years 
of study have identified just a handful of patients 
who carry nonstandard deletions that affect only 
one of the genes and are thus informative (Fig. 1). 
Third, all of the confirmed single-gene mutations 
affect USP9Y; we have no information about the 
phenotype associated with the loss of DDX3Y only.
The study by Luddi et al. clearly shows that 
complete USP9Y deletion is compatible with nor-
mal spermatogenesis and fertility. But previous 
studies5-7 show, equally clearly, that its loss can 
disrupt spermatogenesis to varying degrees and 
that natural transmission (fertility) is possible 
when the phenotype is mild.7 So we have to con-
clude that the phenotype associated with the loss 
of USP9Y varies according to the genetic or other 
background of the carrier, although the relevant 
modifying factors remain unknown. This varia-
tion in phenotype contrasts sharply with the effect 
of losing both genes, which invariably results in 
the Sertoli-cell–only syndrome (characterized by 
the lack of germ cells) and, consequently, azoo-
spermia. This consistent effect strongly suggests 
a key role of DDX3Y in spermatogenesis, a con-
clusion supported by expression of the gene in 
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Figure 1. Known Deletions of the Azoospermia Factor Region a (AZFa) of the Human Y Chromosome and Their As-
sociated Spermatogenic Phenotypes.
Part of the reference sequence, 1 Mb in length, of the Y chromosome is shown (top), highlighting ubiquitin-specific 
peptidase 9, Y-linked gene (USP9Y) and the DEAD (Asp–Glu–Ala–Asp) box polypeptide 3, Y-linked gene (DDX3Y)  
(red arrows) and the two human endogenous retrovirus sequences (HERVs) (orange boxes). Along the same se-
quence, regions are shown (bottom) as retained (black boxes) or missing (thin dotted line) in patients, including the 
standard AZFa deletion resulting from nonallelic homologous recombination between the two HERV sequences, as 
well as confirmed gene-specific deletions. Note the variability in phenotype associated with USP9Y-only deletions 
and the lack of known DDX3Y-only deletions. The white boxes in SAYER (described by Brown et al.6) indicate the ex-
tent of uncertainty in the location of the breakpoint in this patient, and the size of the 4-bp deletion in WHT2780 
(described by Sun et al.5) has been exaggerated to make it visible at this scale. The 1115/0 and A333 deletions are 
described by Krausz et al.7 “Transmitted” indicates a deletion that has been passed naturally from father to son on 
at least one occasion. OAT denotes oligoasthenoteratozoospermia.
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premeiotic spermatogonia (USP9Y is expressed 
in postmeiotic spermatids).11 We predict that the 
loss of DDX3Y alone is associated with a more 
severe testicular phenotype, most likely azoo-
spermia.
What are the clinical implications of these con-
clusions? Screening for USP9Y deletion should not 
be performed routinely until there is a better un-
derstanding of the factors that modify the phe-
notype. Luddi et al. suggest that revision of the 
European Academy of Andrology–European Mo-
lecular Genetics Quality Network screening guide-
lines may be warranted to ensure that DDX3Y-only 
deletions are detected. The lack of confirmed de-
letions of this type after many years of world-
wide screening in research laboratories9 means 
that the cost of such a step may currently out-
weigh the clinical benefit, but we can look for-
ward to a time when the thousand-dollar genome 
will make such information, and much more, 
readily available. In the meantime, the article by 
Luddi et al. focuses our attention even more 
strongly on understanding the role of DDX3Y.
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